Neuraworx Medical Technology, Inc., a neurotechnology company developing first-in-class bioelectronic solutions for brain ...
Return of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026Capital ...
Rise of Direct-to-Patient GLP-1 Sales Shakes Up Care Models, HCPs Split on Pharma’s Expanding Role
Sermo Barometer reveals shifting access pathways, evolving prescribing behavior, and long-term impacts on patient care.NEW ...
Global Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in ...
Athletic trainers can document treatments with the sam® wearable ultrasound device from ZetrOZ Systems to spotlight their ...
Global Cellular Health Screening Market OverviewThe global cellular health screening market was valued at approximately US$ 2 ...
Sobi agrees to buy Arthrosi Therapeutics for up to $1.5 billion, adding the Phase 3 gout asset pozdeutinurad to expand its ...
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has ...
The "Rare Diseases Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The rare diseases treatment market is entering a pivotal phase marked by ...
As Chief Executive Officer of Alexso, Inc., a nationwide pharmaceutical distributor, Farahmand has earned recognition for pairing strategic leadership with compassion at every level of the ...
VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that Dr. Peter Singer, a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback